Clinical Usefulness of Therapeutic Drug Monitoring of Colistin in Patients Treated With Colistin.

N/ACompletedNCT03007290

Seoul National University Hospital15 enrolled

Overview

Clinical usefulness of therapeutic drug monitoring of colistin in patients treated with colistin

Study Type

INTERVENTIONAL

Allocation

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

Conditions

Multidrug-resistant Gram-negative Bacteria Infection

Interventions

Therapeutic drug monitoringOTHER

Therapeutic drug monitoring for colistin

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age over 18 years old. * Those who receive colistin therapy for the treatment of multi-drug resistant gram negative bacteria infection. Exclusion Criteria: * Those who received colistin therapy less than 48 hours * Those who received colistin therapy through the bronchus

Locations (1)

Seoul National University Bundang Hospital

Seongnam, South Korea

Outcomes

Primary Outcomes

AKI

Emergence rate of acute kidney injury

Time frame: Through study completion, an average of 1 month

Secondary Outcomes

Death

Death rate

Time frame: Through study completion, an average of 1 month

Negative conversion rate

Culture-negative conversion rate Treatment success Treatment success

Time frame: Through study completion, an average of 1 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.